Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Lisata Therapeutics (LSTA) over the last 10 years, with Q1 2025 value amounting to $28000.0.

  • Lisata Therapeutics' Capital Expenditures changed N/A to $28000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $28000.0, marking a year-over-year change of. This contributed to the annual value of $285000.0 for FY2022, which is 37500.0% up from last year.
  • As of Q1 2025, Lisata Therapeutics' Capital Expenditures stood at $28000.0.
  • In the past 5 years, Lisata Therapeutics' Capital Expenditures registered a high of $28000.0 during Q1 2025, and its lowest value of $28000.0 during Q1 2025.